Privi Speciality Chemicals Ltd

Privi Speciality Chemicals Capital Structure Change

SBI Mutual Fund sold 18,400 shares of Privi Speciality Chemicals Ltd via open market, reducing its stake from 7.3905% to 7.3434%.

Privi Speciality Chemicals Acquisition

Privi Speciality Chemicals announced an NCLT-convened meeting of equity shareholders for October 27, 2026, to consider the proposed Scheme of Amalgamation involving two transferor companies.

Privi Speciality Chemicals Annual General Meeting

Privi Speciality Chemicals Ltd held its 41st Annual General Meeting on August 7, 2026. The meeting covered financial adoption, dividend declaration, and director appointments.

Privi Speciality Chemicals Earnings Call Transcript: Key Takeaways

Privi reports 19.22% revenue growth and steady 24% EBITDA margins. Management maintains a confident outlook on expansion despite gross margin compression from high raw material costs compared to last year's low-cost base.

Call

Guides 100% growth

Privi Speciality Chemicals Investor Presentation: Key Takeaways

Privi reported strong Q1 FY27 results with 20.01% YoY revenue growth. Strategy focuses on '5k | 1k' vision via capacity expansion and higher-value specialty molecules.

Call

Guides 100% growth

Privi Speciality Chemicals Q1 FY27 Results: Net Profit ₹82.8 Cr, Up 43.7% YoY

Privi Speciality Chemicals Ltd reported revenue from operations of ₹666.2 Cr (+19.2% YoY) and net profit of ₹82.8 Cr (+43.7% YoY) for Q1 FY27.

Key figure

Net profit ₹82.8 Cr · +43.7% YoY

Privi Speciality Chemicals Board Meeting Date

Privi Speciality Chemicals Ltd has scheduled a Board Meeting on July 30, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Privi Speciality Chemicals Other Announcement

Privi Speciality Chemicals dispatched a letter containing the Annual Report web-link for FY 2025-26. The 41st AGM is scheduled for August 07, 2026.

Privi Speciality Chemicals Business Update

Privi Speciality Chemicals Ltd filed its FY 2025-26 BRSR, reporting a turnover of ₹2,056.25 Cr. The filing provides CSR and sustainability disclosures for investors.

Value

₹2,056 Cr

Privi Speciality Chemicals Annual General Meeting

Privi Speciality Chemicals Ltd scheduled its Annual General Meeting for 7 Aug 2026, proposing a final dividend of ₹10 per share. The meeting also ratified cost auditor remuneration of ₹0.09 Crore.

Value

₹0.09 Cr

Privi Speciality Chemicals Annual General Meeting

Privi Speciality Chemicals Limited announced its 41st Annual General Meeting on Friday, August 7 2026 at 4 pm IST. Remote e‑voting will run from August 4 to August 6, 2026.

Privi Speciality Chemicals Credit Rating

Privi Speciality Chemicals received an 'AA Stable' credit rating from ICRA. This rating applies to its Rs.300 Crore long-term bank facility.

Value

₹300.0 Cr

Privi Speciality Chemicals Earnings Call: Key Takeaways

Privi reported strong FY26 performance with 22% revenue growth and 25.76% EBITDA margins, driven by volume growth and improved product mix.

Privi Speciality Chemicals Other Announcement

Privi Speciality Chemicals Limited submitted its Annual Secretarial Compliance Report for the financial year 2025-26. The report confirms overall regulatory adherence with no material non-compliances noted.

Privi Speciality Chemicals Earnings Call: Key Takeaways

Privi delivered strong FY26 performance with 22% revenue growth and 25%+ margins. Management is pivoting from a '5k revenue' goal to a more aggressive long-term trajectory via high-value specialty molecules and backward integration.

Privi Speciality Chemicals Board Meeting Outcome

Privi Speciality Chemicals re-appointed Bhaktavatsala Rao Doppalapudi as Executive Director for three years. Internal and cost auditors were also re-appointed for one-year terms.

Execution

36 months

Privi Speciality Chemicals Dividend

Privi Speciality Chemicals recommended a final dividend of ₹10 per equity share for FY 2025-26. The record date is set for July 31, 2026.

Privi Speciality Chemicals Q4 FY26 Results: Net Profit ₹94.1 Cr, Up 47.0% YoY

Privi Speciality Chemicals Ltd reported revenue from operations of ₹721.5 Cr (+17.6% YoY) and net profit of ₹94.1 Cr (+47.0% YoY) for Q4 FY26.

Key figure

Net profit ₹94.1 Cr · +47.0% YoY

Privi Speciality Chemicals Financial Results

Privi Speciality Chemicals reported its audited FY26 financial results and recommended a 100% final dividend. The board also approved senior leadership re-appointments.

Privi Speciality Chemicals Regulatory Approval

Privi Speciality Chemicals Limited received a 'no objection' observation letter from NSE for its merger scheme with Privi Fine Sciences and Privi Biotechnologies. Approval from BSE is currently awaited. The amalgamation remains subject to further regulatory and statutory clearances.

Privi Speciality Chemicals Board Meeting Date

Privi Speciality Chemicals Limited has scheduled a board meeting for May 11, 2026, to consider audited financial results for the year ended March 31, 2026. The board will also evaluate a final dividend recommendation. The company's trading window is closed from April 1, 2026, until May 13, 2026.

Privi Speciality Chemicals Board Meeting Date

Privi Speciality Chemicals Ltd has scheduled a Board Meeting on May 11, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 31, 2026, and a final dividend declaration.

Privi Speciality Chemicals Credit Rating

Privi Speciality Chemicals Limited announced that CRISIL Ratings has reaffirmed its ratings for ₹1,118 Crore of bank facilities. The long-term rating is reaffirmed at 'CRISIL AA-/Stable' and the short-term rating at 'CRISIL A1+'. These ratings reflect the company's stable credit profile and strong ability to meet financial obligations.

Value

₹1,118 Cr

Privi Speciality Chemicals Other Announcement

Privi Speciality Chemicals Ltd submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended March 31, 2026. The certificate, issued by MUFG Intime India Private Limited, confirms that security certificates received for dematerialisation were processed and the register of members updated within prescribed timelines.